Akèy › Kansè po
Etid klinik pou Kansè po ap rekrite nan Etazini
44 etid pou Kansè po ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA8 etid
- New York City, NY7 etid
- Tampa, FL7 etid
- Salt Lake City, UT6 etid
- Washington, DC6 etid
- Pittsburgh, PA6 etid
- Los Angeles, CA5 etid
- Houston, TX5 etid
- Rochester, MN5 etid
- St. Louis, MO4 etid
- Miami, FL4 etid
- Orlando, FL4 etid
- Atlanta, GA4 etid
- Edison, NJ4 etid
- Jacksonville, FL4 etid
- Aurora, CO4 etid
- Cincinnati, OH3 etid
- Kansas City, MO3 etid
- San Diego, CA3 etid
- Mountain View, CA3 etid
- Providence, RI3 etid
- Birmingham, AL3 etid
- Seattle, WA3 etid
- Morgantown, WV3 etid
- San Francisco, CA3 etid
- Baldwin Park, CA3 etid
- Portland, OR3 etid
- Boca Raton, FL3 etid
- Oklahoma City, OK3 etid
- Dayton, OH3 etid
- Phoenix, AZ3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Arkansas3 etid
- Colorado5 etid
- Florid15 etid
- Georgia4 etid
- Illinois3 etid
- Kalifòni8 etid
- Maryland8 etid
- Massachusetts10 etid
- Michigan3 etid
- Minnesota8 etid
- Missouri5 etid
- New Hampshire3 etid
- New Jersey6 etid
- New York10 etid
- North Carolina4 etid
- Ohio7 etid
- Oklahoma4 etid
- Oregon3 etid
- Pennsylvania8 etid
- Rhode Island3 etid
- Texas6 etid
- Utah6 etid
- Virginia3 etid
- Washington4 etid
- West Virginia3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks – 99 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT00040352Mobile Sun Health Intervention EnabLing Daily Protection
Ap rekriteVolontè an sante akeyi
Laj 18 a 29 · Tout sèks · Mizajou Sep 24, 2026 · NCT07830394Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT05727904Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06585410Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07062003Cryoablation+Ipilimumab+Nivolumab in Melanoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT05779423A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Aug 20, 2026 · NCT02621021High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06298734A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT05859074Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07426484Rural Adult and Youth Sun Protection Study
Ap rekriteVolontè an sante akeyi
Laj 3 a 7 · Tout sèks · Mizajou Aug 10, 2026 · NCT06439979Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06675643The Florida ASCENT Study
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Jul 23, 2026 · NCT07042243DNA Repair Activity in the Skin of Day and Night Shift Workers
Ap rekriteVolontè an sante akeyi
Laj 18 a 40 · Tout sèks · Mizajou Jul 17, 2026 · NCT04122456Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06060613Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06615635Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07327489Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT04975152A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Jun 11, 2026 · NCT05361174A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT07286318Mechanisms for Laser-Induced Rejuvenation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06489301Brodalumab in the Treatment of Immune-Related Adverse Events
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06673329A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou May 8, 2026 · NCT05655494Raman Spectroscopy and Skin Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT06384924Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.